lobbying_activities: 1296082

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1296082	02d69259-cb6b-4b60-8dbd-ae4a0695ce88	Q3	PARRY, ROMANI, DECONCINI & SYMMS	30792	MEDICIS PHARMACEUTICAL CORPORATION	2012	third_quarter	CPT	Oppose bills that prohibit brand name drug companies from settling patent litigation with generic drug companies and for other purposes. S. 27, Preserve Access to Affordable Generics Act and H.R. 3995, Protecting Consumer Access to Generic Drugs Act of 2012.	HOUSE OF REPRESENTATIVES,SENATE	36000		0	0	2012-10-09T13:48:58.033000-04:00